跳至主要内容
临床试验/NCT04467879
NCT04467879终止不适用

A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients

Zona Health, Inc10 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
146
试验地点
10
主要终点
Change from Baseline in Systolic Blood Pressure to Day 70 ± 2 Days

研究概览

简要总结

This is a double-blind, sham-controlled clinical trial assessing the effectiveness of personalized isometric handgrip device therapy. Approximately 230 patients who present with a Systolic Blood Pressure reading of ≤ 149mmHg and who have not taken any antihypertensive medication for more than 30 days will be enrolled.

详细描述

This study is designed to examine the effectiveness of individualized isometric handgrip device therapy in prehypertension or hypertension patient subjects who are not at target BP and who are naive to anti-hypertensive medication for at least 30 days before screening. The investigational plan examines changes in blood pressure (BP) in up to 230 patient subjects who are randomized to either the "active" (i.e., the Zona Plus device proposed for marketing), or to a "sham" device (which is intentionally calibrated for a "weaker grip").

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double Blinded

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change from Baseline in Systolic Blood Pressure to Day 70 ± 2 Days

时间窗: Change from Baseline to Day 70 ±2 Days

Comparative assessment in the change from Baseline in seated cuff Systolic Blood Pressure after ten(10) weeks of treatment between patients treated with the Zona Plus nominal device ("stronger grip") and patients treated with the Placebo control device ("weaker grip"). A reduction in Systolic Blood ≥ 5 Preassure after 10 weeks of treatment is considered to be a better outcome.

次要结局

  • Comparison of Heart Rate between Zona Plus nominal device and Placebo controlled device(Change from Baseline to Day 160 ± 4 Days)
  • Change from Baseline in Diastolic Blood Pressure to Day 70 ± 2 Days(Change from Baseline to Day 70 ±2 Days)
  • Percentage change from Baseline in Systolic Blood Pressure reduction at Day 70 ± 2 Days(Change from Baseline to Day 70 ± 2 Days)
  • Percentage change from Baseline in Diastolic Blood Pressure reduction at Day 70 ± 2 Days(Change from Baseline to Day 70 ± 2 Days)
  • Percentage change in Diastolic Blood Pressure reduction at Day 160 ± 4 Days(Change from Baseline to Day 160 ± 4 Days)
  • Percentage change from Baseline in Systolic Blood Pressure reduction at Day 160 ± 4 Days(Change from Baseline to Day 160 ± 4 Days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

A Pivotal Study To Evaluate The Effectiveness of... | 临床试验